Kaul V, Diehl D, Enslin S, et al. - An IRB-approved multicenter retrospective review was designed to investigate the technical feasibility, safety, and efficacy of powered endoscopic debridement (PED) applying the Endorotor device. Researchers included a total of 34 individuals who had undergone PED with ER device from August 2018 to September 2019 at 4 high-volume U.S. centers. They recorded patient demographics, indication for PED, and procedural and histopathological data. Endorotor was found to be a novel, effective, and safe PED device for endoscopic resection of flat and polypoid lesions in the colon and foregut. It was considered that this may have a promising role in the endoscopic management of naïve and scarred mucosal lesions based on this initial experience. Future prospective studies are required to evrify its role in endoluminal resection.